These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23150180)

  • 1. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.
    Min AK; Jeong JY; Go Y; Choi YK; Kim YD; Lee IK; Park KG
    Diabetologia; 2013 Feb; 56(2):412-22. PubMed ID: 23150180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
    Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
    Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin decreases hepatic SREBP-1c expression and lipid accumulation.
    Seo HY; Kim MK; Jung YA; Jang BK; Yoo EK; Park KG; Lee IK
    Endocrinology; 2013 May; 154(5):1722-30. PubMed ID: 23515283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.
    Zhang C; Wang G; Zheng Z; Maddipati KR; Zhang X; Dyson G; Williams P; Duncan SA; Kaufman RJ; Zhang K
    Hepatology; 2012 Apr; 55(4):1070-82. PubMed ID: 22095841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
    Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway.
    Xia M; Liu Y; Guo H; Wang D; Wang Y; Ling W
    Hepatology; 2013 Aug; 58(2):564-75. PubMed ID: 23300015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
    Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
    J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
    Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
    Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of hepatic CREBH and Insig signaling in the anti-hypertriglyceridemic mechanism of R-α-lipoic acid.
    Tong X; Christian P; Zhao M; Wang H; Moreau R; Su Q
    J Nutr Biochem; 2015 Sep; 26(9):921-8. PubMed ID: 26007286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.
    Yoon YS; Seo WY; Lee MW; Kim ST; Koo SH
    J Biol Chem; 2009 Apr; 284(16):10446-52. PubMed ID: 19244231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
    Kim YW; Kim YM; Yang YM; Kim TH; Hwang SJ; Lee JR; Kim SC; Kim SG
    Free Radic Biol Med; 2010 Feb; 48(4):567-78. PubMed ID: 20005944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation.
    Choi du G; Kim EK; Yang JW; Song JS; Kim YM
    Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver.
    Zhu Y; Lei L; Wang X; Jiang Q; Loor JJ; Kong F; Chen L; Li J; Zhao C; Liu M; Liu G; Li X
    J Dairy Sci; 2023 Aug; 106(8):5626-5635. PubMed ID: 37291038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
    Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
    Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
    Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
    Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
    Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
    J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.